TRVN Market Cap History



Below is a table of the TRVN market cap history going back to 3/17/2014:

Date TRVN Market Cap
3/17/2014221.46M
5/5/2014130.21M
8/8/2014157.11M
11/4/2014166.74M
3/10/2015221.71M
5/4/2015273.13M
8/5/2015278.18M
11/5/2015548.28M
3/3/2016460.14M
5/2/2016398.09M
8/1/2016333.42M
10/31/2016255.39M
3/3/2017238.23M
4/28/2017190.65M
7/31/2017155.81M
10/31/201793.45M
3/2/2018119.85M
4/27/2018126.42M
7/31/2018117.17M
11/2/201858.45M
3/11/2019133.91M
5/8/2019136.68M
8/5/201986.74M
11/1/201991.95M
3/10/202067.72M
5/5/202095.39M
8/7/2020313.28M
10/30/2020411.42M
3/5/2021337.06M
5/4/2021274.84M
8/10/2021236.89M
3/29/202276.80M
5/9/202241.88M
8/9/202236.65M
3/29/20236.55M
5/11/202316.67M
8/10/202312.12M
11/13/20239.09M
3/28/20248.43M

Also see: TRVN Shares Outstanding History
and TRVN YTD Return
TRVN Historical Market Cap:
-27.79% CAGR
TRVN Historical Market Cap: +-27.79% CAGR

Mouse over chart for data details
3/17/2014 ...3/28/2024
Trevena is a biopharmaceutical company. Co.'s primary product, OLINVYK™ (oliceridine) injection, is an opioid agonist for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Co.'s product candidates include: TRV250, which is a G-protein biased delta-opioid receptor agonist as a compound with a mechanism for the treatment of acute migraine; TRV045, which is Co.'s sphingosine-1-phosphate receptor modulator that may provide a non-opioid approach to managing chronic pain; as well as TRV734, a new chemical entity targeting the same mechanism of action at the mu opioid receptor as OLINVYK. We show 39 historical shares outstanding datapoints in our TRVN shares outstanding history coverage, used to compute TRVN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TRVN market cap history over the course of time is important for investors interested in comparing TRVN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TRVN versus a peer is one thing; comparing TRVN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TRVN can fluctuate over the course of history. With this page we aim to empower investors researching TRVN by allowing them to research the TRVN market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree TRVN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Trevena (TRVN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TSBX Market Cap History
TSHA Market Cap History
TSRO Market Cap History
TSVT Market Cap History
TTNP Market Cap History
TTOO Market Cap History
TTPH Market Cap History
TVTX Market Cap History
TVTY Market Cap History
TWST Market Cap History
More Healthcare companies »

 

TRVN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.